Status:
RECRUITING
Effect of Modifying Magnesium Concentration in Citrate-enriched Dialysate on Hemodialysis-associated Thromboinflammation
Lead Sponsor:
Universitair Ziekenhuis Brussel
Collaborating Sponsors:
University of Rochester
Vrije Universiteit Brussel, Jette, Belgium
Conditions:
Hemodialysis
Thromboinflammation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This clinical trial investigates whether the composition of dialysate influences hemodialysis-associated thromboinflammation. Specifically, it evaluates the effects of magnesium concentration and acid...
Eligibility Criteria
Inclusion
- Participants to the OMAGOD pilot trial
Exclusion
- Patients who are not participating in the OMAGOD pilot trial
Key Trial Info
Start Date :
June 5 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT07206524
Start Date
June 5 2025
End Date
December 1 2026
Last Update
November 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitair Ziekenhuis Brussel
Brussels, Belgium, 1090